Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 and RT-PCR in asymptomatic patients: Results of a cohort of workers at El Dorado International Airport in Bogotá, 2020.
Malagón-Rojas J, Gómez-Rendón C, Parra EL, Almentero J, Palma R, López R, Toloza-Pérez YG, Rubio V, Bedoya JF, López-Díaz F, Franco-Muñoz C, Reales-González J, Mercado-Reyes M. Malagón-Rojas J, et al. Among authors: rubio v. Biomedica. 2020 Oct 30;40(Supl. 2):166-172. doi: 10.7705/biomedica.5802. Biomedica. 2020. PMID: 33152200 Free PMC article. English, Spanish.
Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.
Malagón-Rojas JN, Mercado-Reyes M, Toloza-Pérez YG, Parra Barrera EL, Palma M, Muñoz E, López R, Almentero J, Rubio VV, Ibáñez E, Téllez E, Delgado-Murcia LG, Jimenez CP, Viasus-Pérez D, Galindo M, Lagos L; Interinstitutional Support Group. Malagón-Rojas JN, et al. Among authors: rubio vv. Occup Environ Med. 2022 Jun;79(6):388-395. doi: 10.1136/oemed-2021-107487. Epub 2021 Nov 5. Occup Environ Med. 2022. PMID: 34740981 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study.
Mercado-Reyes M, Malagón-Rojas J, Rodríguez-Barraquer I, Zapata-Bedoya S, Wiesner M, Cucunubá Z, Toloza-Pérez YG, Hernández-Ortiz JP, Acosta-Reyes J, Parra-Barrera E, Ibáñez-Beltrán E, Quinche GG, Muñoz-Galindo L, Rubio V, Galindo-Borda M, Osorio-Velázquez EG, Bermúdez-Forero A, Pinto-Chacón N, Puerto-Castro G, Franco-Muñoz C, Estupiñan MI, Villar LÁ, Gore-Saravia N, Miranda-Montoya MC, Castellanos J, Valle EM, Navarro-Lechuga E, Oviedo JD, Ospina-Martínez M. Mercado-Reyes M, et al. Among authors: rubio v. Lancet Reg Health Am. 2022 May;9:100195. doi: 10.1016/j.lana.2022.100195. Epub 2022 Feb 5. Lancet Reg Health Am. 2022. PMID: 35156075 Free PMC article.
[National Network for Knowledge Management, Research, and Innovation in Tuberculosis in ColombiaRede Nacional de Gestão do Conhecimento, Pesquisa e Inovação em tuberculose na Colômbia].
Rincón-Torres CE, Rubio V, Castro C, García I, Cruz OA, Trujillo-Trujillo J, Puerto GM. Rincón-Torres CE, et al. Among authors: rubio v. Rev Panam Salud Publica. 2021 Feb 26;45:e23. doi: 10.26633/RPSP.2021.23. eCollection 2021. Rev Panam Salud Publica. 2021. PMID: 33643403 Free PMC article. Spanish.
New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF, Cuartas V, Bernal A, Insuasty A, Guzman J, Vidal O, Rubio V, Puerto G, Lukáč P, Vimberg V, Balíková-Novtoná G, Vannucci L, Janata J, Quiroga J, Abonia R, Nogueras M, Cobo J, Insuasty B. Castaño LF, et al. Among authors: rubio v. Eur J Med Chem. 2019 Aug 15;176:50-60. doi: 10.1016/j.ejmech.2019.05.013. Epub 2019 May 7. Eur J Med Chem. 2019. PMID: 31096118
Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety.
Castaño LF, Quiroga J, Abonia R, Insuasty D, Vidal OM, Seña R, Rubio V, Puerto G, Nogueras M, Cobo J, Guzman J, Insuasty A, Insuasty B. Castaño LF, et al. Among authors: rubio v. Int J Mol Sci. 2022 Oct 20;23(20):12589. doi: 10.3390/ijms232012589. Int J Mol Sci. 2022. PMID: 36293443 Free PMC article.
QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis.
Valencia J, Rubio V, Puerto G, Vasquez L, Bernal A, Mora JR, Cuesta SA, Paz JL, Insuasty B, Abonia R, Quiroga J, Insuasty A, Coneo A, Vidal O, Márquez E, Insuasty D. Valencia J, et al. Among authors: rubio v. Antibiotics (Basel). 2022 Dec 29;12(1):61. doi: 10.3390/antibiotics12010061. Antibiotics (Basel). 2022. PMID: 36671262 Free PMC article.
408 results